India faces significant risks from climate change, including sea-level rise, extreme heat, and seve…

Swiggy will launch its IPO with a price band of ₹371-₹390 per share on November 6. A Blinkit custom…

According to a report by Nuvama Wealth Management, in the past two quarters, the capex to GDP ratio…

Although the detrimental effects of climate change on economies have been acknowledged, quantifying…

This victory indicates continuity in policy, particularly in infrastructure spending and boosting d…

The US economy grew by 2.8% last quarter, much higher than expected. Traders will be assessing the …

Many of the richest Indian states have expressed mixed to lukewarm reactions towards the Bharatiya …

Indian stock markets are geared up for a dynamic performance in the coming week, influenced by a mu…

GDP grew above-expected last quarter, with the economy expanding 2.8%, per advanced estimates.

Investors will get a fresh inflation reading, with implications for Fed policy as the markets heads…

The active ingredient in Ozempic, semaglutide, mimics GLP-1, a hormone that makes you feel full.

After failing to finish projects and repay lenders, Evergrande now holds the unfortunate title as t…

Weight-loss drugs like Ozempic have fueled a rally in pharmaceutical stocks in 2024, as investors e…

Reducing obesity via GLP-1 drugs could create healthier workforces, spike productivity, reduce abse…

Economists have had to admit their forecasts of a Russian GDP crash were wrong, the Institute for B…

In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlin…

Key stock indices suffered their worst single-day losses in percentage terms since June 13, 2…

In the three-day deliberations of the Monetary Policy Committee of the Reserve Bank of India in ear…

S&P Global Ratings on Monday cut India's economic growth forecast for current fiscal year to 7 per …

The International Monetary Fund (IMF) in its flagship World Economic Outlook projected that India w…